Literature DB >> 26657862

MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.

Mick D Edmonds, Kelli L Boyd, Tamara Moyo, Ramkrishna Mitra, Robert Duszynski, Maria Pia Arrate, Xi Chen, Zhongming Zhao, Timothy S Blackwell, Thomas Andl, Christine M Eischen.   

Abstract

MicroRNA (miR) are important regulators of gene expression, and aberrant miR expression has been linked to oncogenesis; however, little is understood about their contribution to lung tumorigenesis. Here, we determined that miR-31 is overexpressed in human lung adenocarcinoma and this overexpression independently correlates with decreased patient survival. We developed a transgenic mouse model that allows for lung-specific expression of miR-31 to test the oncogenic potential of miR-31 in the lung. Using this model, we observed that miR-31 induction results in lung hyperplasia, followed by adenoma formation and later adenocarcinoma development. Moreover, induced expression of miR-31 in mice cooperated with mutant KRAS to accelerate lung tumorigenesis. We determined that miR-31 regulates lung epithelial cell growth and identified 6 negative regulators of RAS/MAPK signaling as direct targets of miR-31. Our study distinguishes miR-31 as a driver of lung tumorigenesis that promotes mutant KRAS-mediated oncogenesis and reveals that miR-31 directly targets and reduces expression of negative regulators of RAS/MAPK signaling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26657862      PMCID: PMC4701567          DOI: 10.1172/JCI82720

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

Authors:  A Sewing; B Wiseman; A C Lloyd; H Land
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.

Authors:  Chad J Creighton; Michael D Fountain; Zhifeng Yu; Ankur K Nagaraja; Huifeng Zhu; Mahjabeen Khan; Emuejevoke Olokpa; Azam Zariff; Preethi H Gunaratne; Martin M Matzuk; Matthew L Anderson
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

3.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma.

Authors:  Chung-Ji Liu; Meng-Miao Tsai; Pei-Shih Hung; Shou-Yen Kao; Tsung-Yun Liu; Kou-Juey Wu; Shih-Hwa Chiou; Shu-Chun Lin; Kuo-Wei Chang
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

4.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

Authors:  Stefan Costinean; Nicola Zanesi; Yuri Pekarsky; Esmerina Tili; Stefano Volinia; Nyla Heerema; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

5.  MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.

Authors:  Xi Liu; Lorenzo F Sempere; Haoxu Ouyang; Vincent A Memoli; Angeline S Andrew; Yue Luo; Eugene Demidenko; Murray Korc; Wei Shi; Meir Preis; Konstantin H Dragnev; Hua Li; James Direnzo; Mads Bak; Sarah J Freemantle; Sakari Kauppinen; Ethan Dmitrovsky
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

6.  Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.

Authors:  Junming Guo; Ying Miao; Bingxiu Xiao; Rong Huan; Zhen Jiang; Dan Meng; Yanjun Wang
Journal:  J Gastroenterol Hepatol       Date:  2008-11-03       Impact factor: 4.029

7.  Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.

Authors:  Amer M Mirza; Stephan Gysin; Nisar Malek; Kei-ichi Nakayama; James M Roberts; Martin McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 8.  The biological functions of miRNAs: lessons from in vivo studies.

Authors:  Joana A Vidigal; Andrea Ventura
Journal:  Trends Cell Biol       Date:  2014-12-04       Impact factor: 20.808

9.  Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer.

Authors:  Shuang Wang; Jun Zhou; Xiao-Yan Wang; Jun-Mei Hao; Juan-Zhi Chen; Xiang-Mei Zhang; He Jin; Li Liu; Yan-Fei Zhang; Jinsong Liu; Yan-Qing Ding; Jian-Ming Li
Journal:  J Pathol       Date:  2009-09       Impact factor: 7.996

10.  The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.

Authors:  Peter M K Westcott; Kyle D Halliwill; Minh D To; Mamunur Rashid; Alistair G Rust; Thomas M Keane; Reyno Delrosario; Kuang-Yu Jen; Kay E Gurley; Christopher J Kemp; Erik Fredlund; David A Quigley; David J Adams; Allan Balmain
Journal:  Nature       Date:  2014-11-02       Impact factor: 49.962

View more
  42 in total

1.  High-Resolution In Vivo Identification of miRNA Targets by Halo-Enhanced Ago2 Pull-Down.

Authors:  Xiaoyi Li; Yuri Pritykin; Carla P Concepcion; Yuheng Lu; Gaspare La Rocca; Minsi Zhang; Bryan King; Peter J Cook; Yu Wah Au; Olesja Popow; Joao A Paulo; Hannah G Otis; Chiara Mastroleo; Paul Ogrodowski; Ryan Schreiner; Kevin M Haigis; Doron Betel; Christina S Leslie; Andrea Ventura
Journal:  Mol Cell       Date:  2020-06-03       Impact factor: 17.970

Review 2.  Function and regulation of microRNA-31 in development and disease.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Mol Reprod Dev       Date:  2016-08-02       Impact factor: 2.609

Review 3.  Targeting noncoding RNAs in disease.

Authors:  Brian D Adams; Christine Parsons; Lisa Walker; Wen Cai Zhang; Frank J Slack
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

4.  The functional activity of the miR-1914-5p in lipid metabolism of the hepatocarcinoma cell line HepG2: a potential molecular tool for controlling hepatic cellular migration.

Authors:  Marina Bonfogo da Silveira; Camila Cristiane Pansa; Osmar Malaspina; Karen C M Moraes
Journal:  Mol Biol Rep       Date:  2021-04-28       Impact factor: 2.316

Review 5.  The Role of Non-coding RNAs in Oncology.

Authors:  Frank J Slack; Arul M Chinnaiyan
Journal:  Cell       Date:  2019-11-14       Impact factor: 41.582

6.  MicroRNA-509-3p inhibits cell proliferation and invasion via downregulation of X-linked inhibitor of apoptosis in glioma.

Authors:  Peng Du; Xinping Luan; Yiwei Liao; Yiti Mu; Yang Yuan; Jingxuan Xu; Jingjing Zhang
Journal:  Oncol Lett       Date:  2017-11-10       Impact factor: 2.967

7.  Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.

Authors:  Asawari Korde; Lei Jin; Jian-Ge Zhang; Anuradha Ramaswamy; Buqu Hu; Saeed Kolahian; Brenda Juan Guardela; Jose Herazo-Maya; Jill M Siegfried; Laura Stabile; Margaret A Pisani; Roy S Herbst; Naftali Kaminski; Jack A Elias; Jonathan T Puchalski; Shervin S Takyar
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

8.  MiR-31 Mediates Inflammatory Signaling to Promote Re-Epithelialization during Skin Wound Healing.

Authors:  Jianyun Shi; Xianghui Ma; Yang Su; Yongli Song; Yuhua Tian; Shukai Yuan; Xiuqing Zhang; Dong Yang; Hao Zhang; Jianwei Shuai; Wei Cui; Fazheng Ren; Maksim V Plikus; Yaoxing Chen; Jie Luo; Zhengquan Yu
Journal:  J Invest Dermatol       Date:  2018-03-30       Impact factor: 8.551

9.  Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion.

Authors:  Evan J Greenawalt; Mick D Edmonds; Neha Jain; Clare M Adams; Ramkrishna Mitra; Christine M Eischen
Journal:  Mol Cancer Res       Date:  2018-09-26       Impact factor: 5.852

Review 10.  Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems.

Authors:  Rami Alzhrani; Hashem O Alsaab; Alex Petrovici; Ketki Bhise; Kushal Vanamala; Samaresh Sau; Matthew J Krinock; Arun K Iyer
Journal:  Drug Discov Today       Date:  2019-11-20       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.